Skip to main content
OpenTrials

Clinical trial condition

Dwarfism

Explore clinical trials studying Dwarfism. Study availability and eligibility vary by location and protocol.

231 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Dwarfism trial results

Not Yet Recruiting

Growing up With the Young Endocrine Support System (YESS!)

NCT04252001

Conditions
Addison Disease, Addison's Disease, Adrenal Gland Diseases, +53 more
Locations
  • Ghent University Hospital Ghent, Belgium
  • Erasmus Medical Center Rotterdam, South Holland, Netherlands
  • Hospital Infantil Universitario Niño Jesús Madrid, Spain
  • Queen Elizabeth University Hospital Glasgow, United Kingdom
View Trial Details
Completed

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia

NCT05598320

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +5 more
Locations
  • Ascendis Pharma Investigational Site Saint Paul, Minnesota, United States
  • Ascendis Pharma Investigational Site Columbia, Missouri, United States
  • Ascendis Pharma Investigational Site Houston, Texas, United States
  • Ascendis Pharma Investigational Site Madison, Wisconsin, United States
View Trial Details
Completed

Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

NCT01947907

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +11 more
Locations
  • 2nd Children City Clinic Minsk, Belarus
  • University Multiprofile Hospital for Active Treatment (UMHAT) "Sv. Marina" Varna, Bulgaria
  • Masaryk´s Hospital Ústí nad Labem, Czechia
  • El Shatby University Hospital Alexandria, Egypt
View all 36 locations
View Trial Details
Completed

A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency

NCT05171855

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Ascendis Pharma Investigational Site Phoenix, Arizona, United States
  • Ascendis Pharma Investigational Site Torrance, California, United States
  • Ascendis Pharma Investigational Site Chicago, Illinois, United States
  • Ascendis Pharma Investigational Site Indianapolis, Indiana, United States
View all 85 locations
View Trial Details
Completed

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

NCT02781727

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +16 more
Locations
  • Ascendis Pharma Investigational Site Birmingham, Alabama, United States
  • Ascendis Pharma Investigational Site Little Rock, Arkansas, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Orange, California, United States
View all 53 locations
View Trial Details
Completed

A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency

NCT03305016

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +15 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Neufeld Medical Group Inc. Los Angeles, California, United States
  • Center of Excellence in Diabetes and Endocrinology Sacramento, California, United States
  • Rocky Mountain Pediatric Endocrinology Centennial, Colorado, United States
View all 24 locations
View Trial Details
Completed

A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency

NCT04615273

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +15 more
Locations
  • Ascendis Pharma Investigational Site Birmingham, Alabama, United States
  • Ascendis Pharma Investigational Site Phoenix, Arizona, United States
  • Ascendis Pharma Investigational Site Fresno, California, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
View all 113 locations
View Trial Details

Related conditions